Major near-term changes in the US FDA’s regulatory framework governing medical product communications are unlikely due, in part, to other matters currently on new Commissioner Scott Gottlieb’s plate, an attorney for a coalition of drug and device manufacturers said.
The Medical Information Working Group (MIWG) is a group of 13 companies focused on getting clarity on FDA’s regulatory framework...







